U.S Physical Therapy Debt to Equity Ratio 2010-2024 | USPH

Current and historical debt to equity ratio values for U.S Physical Therapy (USPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. U.S Physical Therapy debt/equity for the three months ending March 31, 2024 was 0.28.
U.S Physical Therapy Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.54B $0.48B 1.11
2023-12-31 $0.52B $0.48B 1.09
2023-09-30 $0.52B $0.49B 1.05
2023-06-30 $0.51B $0.49B 1.04
2023-03-31 $0.55B $0.32B 1.72
2022-12-31 $0.54B $0.32B 1.71
2022-09-30 $0.48B $0.32B 1.51
2022-06-30 $0.49B $0.31B 1.58
2022-03-31 $0.46B $0.30B 1.53
2021-12-31 $0.45B $0.30B 1.52
2021-09-30 $0.34B $0.29B 1.17
2021-06-30 $0.34B $0.29B 1.19
2021-03-31 $0.32B $0.28B 1.16
2020-12-31 $0.32B $0.28B 1.14
2020-09-30 $0.31B $0.27B 1.16
2020-06-30 $0.33B $0.26B 1.28
2020-03-31 $0.40B $0.24B 1.66
2019-12-31 $0.32B $0.24B 1.32
2019-09-30 $0.33B $0.24B 1.38
2019-06-30 $0.33B $0.23B 1.41
2019-03-31 $0.30B $0.22B 1.37
2018-12-31 $0.23B $0.22B 1.04
2018-09-30 $0.24B $0.21B 1.14
2018-06-30 $0.23B $0.21B 1.07
2018-03-31 $0.21B $0.21B 1.00
2017-12-31 $0.21B $0.21B 1.03
2017-09-30 $0.21B $0.20B 1.06
2017-06-30 $0.22B $0.20B 1.13
2017-03-31 $0.20B $0.19B 1.01
2016-12-31 $0.16B $0.19B 0.86
2016-09-30 $0.09B $0.22B 0.42
2016-06-30 $0.10B $0.21B 0.46
2016-03-31 $0.10B $0.21B 0.49
2015-12-31 $0.13B $0.17B 0.76
2015-09-30 $0.09B $0.19B 0.48
2015-06-30 $0.09B $0.18B 0.47
2015-03-31 $0.08B $0.18B 0.46
2014-12-31 $0.08B $0.17B 0.46
2014-09-30 $0.09B $0.16B 0.52
2014-06-30 $0.08B $0.16B 0.47
2014-03-31 $0.07B $0.15B 0.48
2013-12-31 $0.07B $0.15B 0.48
2013-09-30 $0.03B $0.15B 0.23
2013-06-30 $0.04B $0.15B 0.24
2013-03-31 $0.04B $0.14B 0.27
2012-12-31 $0.04B $0.14B 0.28
2012-09-30 $0.03B $0.14B 0.25
2012-06-30 $0.04B $0.13B 0.29
2012-03-31 $0.04B $0.13B 0.31
2011-12-31 $0.04B $0.12B 0.34
2011-09-30 $0.04B $0.12B 0.34
2011-06-30 $0.03B $0.12B 0.28
2011-03-31 $0.03B $0.11B 0.30
2010-12-31 $0.02B $0.12B 0.21
2010-09-30 $0.02B $0.11B 0.19
2010-06-30 $0.02B $0.10B 0.20
2010-03-31 $0.03B $0.10B 0.30
2009-12-31 $0.02B $0.09B 0.21
2009-09-30 $0.02B $0.09B 0.24
2009-06-30 $0.03B $0.09B 0.31
2009-03-31 $0.03B $0.09B 0.36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.424B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00